UMC IDMP Request and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: MedicinalProductDefinition (Auro methotrexate) - XML Representation

Raw xml | Download

<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="1A0661AE2A40"/>
  <meta>
    <versionId value="1"/>
    <lastUpdated value="2018-02-24T08:23:55.3332666+00:00"/>
    <source value="https://poc-idmp.who-umc.org/fhir"/>
    <profile
             value="http://who-umc.org/idmp/StructureDefinition/MedicinalProductDefinition-who-php-pub"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml" style="font-family: Helvetica;"><h1 style="color: darkblue; background: lightgray; padding: 5px;">Medicinal Product (Medicinal Product Definition)</h1><table style="padding: 5px; text-align: left;"><tr><td style="font-weight: bold;">Id</td><td>1A0661AE2A40</td></tr><tr><td style="font-weight: bold;">Name</td><td>Auro methotrexate</td></tr><tr><td style="font-weight: bold;">Mah</td><td>Auro Pharma Inc</td></tr><tr><td style="font-weight: bold;">Jurisdiction</td><td>Canada</td></tr></table><h2 style="color: darkblue; background: lightgray; padding: 5px;">ATC</h2><table style="padding: 5px; text-align: left;"><th>Code</th><th>Display</th><tr><td>G02CX</td><td>Other gynecologicals</td></tr><tr><td>L01BA</td><td>Folic acid analogues</td></tr><tr><td>L04AX</td><td>Other immunosuppressants</td></tr></table><h2 style="color: darkblue; background: lightgray; padding: 5px;">Codes</h2><table style="padding: 5px; text-align: left;"><th>System</th><th>Code</th><th>Display</th><tr><td>http://who-umc.org/idmp/CodeSystem/drugcode</td><td>00113802216</td><td/></tr></table><h2 style="color: darkblue; background: lightgray; padding: 5px;">PhPIDs</h2><table style="padding: 5px; text-align: left;"><th>Level</th><th>Code</th><tr><td>4</td><td>91B3CA582581F57E4092F13AAF476215</td></tr></table></div>
  </text>
  <contained>
    <Organization>
      <id value="auropharmainc"/>
      <name value="Auro Pharma Inc"/>
    </Organization>
  </contained>
  <contained>
    <RegulatedAuthorization>
      <id value="regauth"/>
      <subject>
        <reference value="#"/>
      </subject>
      <holder>
        <reference value="#auropharmainc"/>
      </holder>
    </RegulatedAuthorization>
  </contained>
  <identifier>
    <system value="https://gupri-idmp.who-umc.org/data/record"/>
    <value value="1A0661AE2A40"/>
  </identifier>
  <identifier>
    <system value="https://health-products.canada.ca/dpd-bdpp"/>
    <value value="02182750"/>
  </identifier>
  <type>
    <coding>
      <system value="http://hl7.org/fhir/medicinal-product-type"/>
      <code value="MedicinalProduct"/>
    </coding>
  </type>
  <domain>
    <coding>
      <system value="http://hl7.org/fhir/medicinal-product-domain"/>
      <code value="Human"/>
    </coding>
    <text value="Human use"/>
  </domain>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
    </coding>
    <text value="Active"/>
  </status>
  <combinedPharmaceuticalDoseForm>
    <text value="TABLETS"/>
  </combinedPharmaceuticalDoseForm>
  <classification>
    <coding>
      <system value="http://who-umc.org/idmp/level4-phpid"/>
      <code value="91B3CA582581F57E4092F13AAF476215"/>
    </coding>
  </classification>
  <classification>
    <coding>
      <system value="http://www.whocc.no/atc"/>
      <code value="G02CX"/>
    </coding>
    <text value="Other gynecologicals"/>
  </classification>
  <classification>
    <coding>
      <system value="http://www.whocc.no/atc"/>
      <code value="L01BA"/>
    </coding>
    <text value="Folic acid analogues"/>
  </classification>
  <classification>
    <coding>
      <system value="http://www.whocc.no/atc"/>
      <code value="L04AX"/>
    </coding>
    <text value="Other immunosuppressants"/>
  </classification>
  <code>
    <system value="http://who-umc.org/idmp/CodeSystem/drugcode"/>
    <code value="00113802216"/>
  </code>
  <name>
    <productName value="Auro methotrexate"/>
    <usage>
      <country>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="CAN"/>
        </coding>
      </country>
      <jurisdiction>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="CAN"/>
        </coding>
      </jurisdiction>
      <language>
        <coding>
          <system value="urn:ietf:bcp:47"/>
          <code value="en"/>
        </coding>
      </language>
    </usage>
  </name>
</MedicinalProductDefinition>